Dr. Ratmir Derda’s achievements were recently recognized with an award at BioAlberta’s 2021 Awards Gala.
Category: Community
GlycoNet investigator presents game-changing glycomics research to the Parliamentary Health Research Caucus
Dr. Lori Burrows shared how glycomics research is being used to develop a more effective vaccine against turberculosis.
New educational resources bolster vaccine confidence, information literacy
GlycoNet received a NSERC PromoScience grant and partnered with the Centre for Mathematics, Science and Technology Education to develop resources that educators can use to teach the science behind vaccines and engage students in critical thinking.
Op-ed: Glycomics is the new frontier in bioinnovation
Read about the future of glycomics in this op ed by GlycoNet board chair Karimah Es Sabar, republished from the Hill Times. Canada has a tremendous opportunity with continued investment in glycomics to establish global leadership and economic prosperity while at the same time solving some of the world’s most pressing challenges in health and environmental sustainability.
Glycomics: The New Frontier in Bioinnovation
In our new report: Why glycomics, the study of sugars on cells, is at the centre of a new surge of scientific and industry interest.
Top 10 stories from GlycoNet in 2021
A year in review in glycomics innovations.
Announcing the new GlycoNet Trainee Association Executive Committee
The committee will support GlycoNet trainees in advancing their skills and knowledge through professional development activities.
GlycoNet Mini-Symposium gathered trainees from coast to coast
The event brought together trainees from Western, Central, and East Coast regions to network and exchange knowledge.
GlycoNet receives government funding to encourage confidence in vaccines across the country
The grant will help deliver reliable vaccine information to help Canadians make evidence-based decisions on vaccines.
GlycoNet start-up listed as top 10 therapeutics start-ups and companies in Edmonton
48Hour Discovery shows exceptional innovation, growth, management, and societal impact, according to BestStartup.